2022 annual financial data
Pacific Biosciences of California 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -205.15%.
Operating income was -307,196,000 USD and net income was -314,248,000 USD.
Operating cash flow was -263,211,000 USD.
Get free Pacific Biosciences of California email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 128,304,000 USD
- Operating income
- -307,196,000 USD
- Net income
- -314,248,000 USD
- Operating cash flow
- -263,211,000 USD